Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Frasers disappoints as FY profits hit low end of guidance

(Sharecast News) - Shares in Frasers Group dropped on Thursday after the retail conglomerate released its full-year results, in which adjusted profits came in at the lower end of the guidance range and domestic sales fell. The Sports Direct, Jack Wills and Sofa.com owner said adjusted profit before tax (PBT) was 2.8% higher than last year at £560.2m over the 12 months to 27 April, as a 1.5% decline in the first half was met with an 8.3% improvement in the second.

However, this was still towards the lower end of the £550m-600m guidance range given at its half-year results in December.

The company also gave the same guidance range for the current fiscal year, held back by £50m of incremental costs as a result of changes in last year's Autumn Budget.

Shares were down 4.3% at 617.28p in early deals in London.

Group revenues were down 7.4% over the year to £4.93bn, with a 7.2% drop in its UK sports retail division to £2.70bn and a 14.8% plunge in premium lifestyle to £1.05bn offsetting a 1.3% improvement in international operations to £1.01bn.

Reported PBT dropped 24.3% to £379.4m, held back by FX losses (compared with gains the previous year) and the fair value movements on equity derivatives, primarily relating to a "material decline" in the share price of Hugo Boss, in which the company owns a 19.2% stake.

Looking ahead, the retailer said that recent sales trends "have been more encouraging" following a weak period last year, with both UK consumer confidence and trading conditions improving.

"For FY26, we are mindful of the various macro headwinds and still expect to incur at least £50m of incremental costs as a result of last year's Budget, but we are working hard to mitigate those by taking more costs out, focussing on potential efficiencies through the use of AI, realising further acquisition synergies, and sustaining a robust gross margin," the company said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.